Evolus
Develops and sells medical aesthetic injectable treatments.
Company facts
- Founded
- 2012
- Employees
- 334
- Headquarters
- United States
- CEO
- David Moatazedi
- Type
- Public
- Listed
- NASDAQ: EOLS
- Subsidiaries
- Jeuveau, Nuceiva, Evolysse
About
Evolus, Inc. is a performance beauty company focused on providing innovative aesthetic treatments and products in the cash-pay marketplace. With a clear commitment to making beauty experiences delightful and achievable for everyone, Evolus strives to enhance the way individuals engage with aesthetic procedures. The company's flagship product is Jeuveau, a botulinum toxin product specifically formulated for temporary improvement in the appearance of frown lines. This proprietary formulation positions Evolus uniquely within the aesthetic industry, catering particularly to consumers looking for effective, non-surgical solutions. Founded in 2012 and headquartered in Newport Beach, California, Evolus has rapidly scaled its operations, and as of today, they have successfully enrolled over one million consumers in Evolus Rewards, a co-branded loyalty program designed to incentivize repeat visits to aesthetic practices. The essence of Evolus revolves around providing extended choices in aesthetic treatments, thereby fostering a consumer-centric environment where patients feel valued and appreciated. The company's growth and innovation strategies have thus emphasized performance and accessibility, aiming to break barriers in the aesthetic industry.